|
at 07:30 |
|
|
Knight Therapeutics Inc. ("Knight"), a leading pan-American (ex-USA) specialty pharmaceutical company, will release its first quarter 2024 financial results on Thursday, May 9, 2024 prior to market opening. Following the release, Knight will hold a...
|
|
at 07:30 |
|
|
Quipt Home Medical Corp. (the "Company") ?, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, announced today that the Toronto Stock Exchange ("TSX") has accepted the Company's notice of intention to implement a...
|
|
at 07:30 |
|
|
Stack Capital Group Inc., ("Stack Capital" or the "Company") today announced its financial results for the quarter ended March 31, 2024. Stack Capital reports all amounts in Canadian Dollars unless otherwise stated. Company Commentary: As at March...
|
|
at 07:30 |
|
|
End-of-treatment data from two Phase 2a combination clinical trials with imdusiran to be presented at the EASL Congress in June 2024 Preliminary data from the single-dose portion of the AB-101-001 clinical trial show that AB-101 was generally...
|
|
at 07:25 |
|
|
Arbutus Biopharma Corporation ("Arbutus" or the "Company"), a clinical-stage biopharmaceutical company leveraging its extensive virology expertise to develop a functional cure for people with chronic hepatitis B virus (cHBV) infection, today...
|
|
at 07:20 |
|
|
Building on their successful partnership, INVNT GROUP and MSM (Media & Sport Management) enhance service offerings and commercial solutions tailored for talent and brands within the booming motorsports industry. INVNT GROUP, the global brand...
|
|
|
